Navigation Links
Igenica Appoints Thi-Sau Migone, Ph.D., as Chief Scientific Officer
Date:4/9/2013

ne.  "I am delighted to have this opportunity to contribute to Igenica's success."

About Igenica, Inc.

Igenica, Inc. is a biopharmaceutical company pioneering breakthrough antibody-based cancer medicines. The company has integrated innovative technology platforms to address the major challenges to developing effective treatments for multiple oncology indications, with sTAg, a forward-looking proteomics approach to discovering novel tumor antigens, iTAb, a functional in vivo antibody screening approach, and next generation antibody-drug conjugate technology.  Igenica's technology platforms drive innovative drug discovery and promise to identify novel and more effective cancer therapeutics.

Igenica's Board of Directors includes David Goeddel , Ph.D., The Column Group; John Diekman , Ph.D., 5AM Ventures; Mark A. Goldsmith , M.D., Ph.D., Third Rock Ventures; Carl Gordon , Ph.D., CFA, Orbimed Advisors; Mary Haak-Frendscho , Ph.D., Igenica, Inc.; Robert Schreiber , Ph.D., Igenica Founder and Alumni Endowed Professor of Pathology and Immunology, Professor of Molecular Microbiology and Tumor Immunology Program Leader for the Siteman Comprehensive Cancer Center at Washington University School of Medicine.

Contact:
John K. Celebi , MBA
Chief Business Officer
Igenica, Inc.
(650) 231-4320


'/>"/>
SOURCE Igenica, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Igenica Closes $33 Million in Series C Funding
2. Igenica Appoints Mary Haak-Frendscho, Ph.D., as Chief Executive Officer
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
5. Nephros Appoints John C. Houghton as President and Chief Executive Officer
6. Elsevier Appoints New President of Elsevier CPM Resource Center
7. GenWay Biotech Appoints New Vice President of Custom/OEM
8. Angeion Appoints Matthew S. Margolies as Executive Vice President - Global Sales
9. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
10. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
11. Hill-Rom Appoints Alton Shader President of Hill-Rom North America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 1, 2015  Research Solutions, Inc. (OTCQB: RSSS), a pioneer ... (STM) information for life science companies, academic institutions, and ... at the LD Micro Invitational being held on June ... Los Angeles . ... June 3rd at 9:30 a.m. Pacific time, with one-on-one ...
(Date:6/1/2015)... 2015  Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today ... as ,nal-IRI, in a Phase 1 investigator-sponsored study at ... Data were presented at the 2015 American Society of ... IL. Results from this study show a ... glioma when given intravenously.  Based in part ...
(Date:6/1/2015)... 2015 About Pressure Relief ... area and improve the quality life of patients who ... play a significant role in inhibiting the growth and ... to turn or rotate an immobile patient by providing ... overlay, and specialty beds. These devices have the ability ...
Breaking Medicine Technology:Research Solutions to Present at the LD Micro Invitational on June 3, 2015 2Research Solutions to Present at the LD Micro Invitational on June 3, 2015 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 5Global Pressure Relief Devices Market 2015-2019 2Global Pressure Relief Devices Market 2015-2019 3
... MOUNTAIN VIEW, Calif., July 20, 2011 Concentric Medical, ... in ischemic stroke patients, today announced the launch of ... the addition of the V 2.0 Soft and V ... of V Series Merci Retrievers® are now approved and ...
... DALLAS, July 20, 2011 ,   ... reports,on The Outlook for Pharmaceuticals for BRIC, Central & ... as well,as E7 countries in its store ... market cover the outlook for pharmaceuticals in,emerging E7 countries as ...
Cached Medicine Technology:Concentric Medical Launches Full Family of Merci Retrievers® in Japan 2Concentric Medical Launches Full Family of Merci Retrievers® in Japan 3ReportsnReports - The Outlook for Pharmaceuticals (BRIC, Asia, Europe, E7) 2ReportsnReports - The Outlook for Pharmaceuticals (BRIC, Asia, Europe, E7) 3ReportsnReports - The Outlook for Pharmaceuticals (BRIC, Asia, Europe, E7) 4
(Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... Lynn Lester as a 2015-2016 inductee into ... recognized with this prestigious distinction for leadership in business. ... professional women, boasting more than 700,000 members and over ... Lynn Lester with this prestigious award,” said NAPW President ...
(Date:6/1/2015)... 2015 The National Association of ... 2015-2016 inductee into its VIP Woman of the ... distinction for leadership in business. NAPW is the ... boasting more than 700,000 members and over 200 ... Kathy into this exceptional group of professional women,” ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Ticket Down announces ... the NBA Western Conference Finals and now will face the ... will be held at the Oracle Arena in Oakland and ... the 2014-15 National Basketball Association season, the Golden State Warriors ... were a team that learned from their playoff failures from ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Linda Kincaid, age ... had an irregular heartbeat. At first she thought it was ... out it was much more than that. After going to ... Linda admitted she felt afraid about what might happen to ... million Americans are diagnosed with valve disease each year. Valve ...
(Date:6/1/2015)... June 01, 2015 Cambia Health ... today a new, interactive Affordable Care Act (ACA) ... The course, called “Affordable Care Act Expert Series, ... the strategic and consultative insights necessary to effectively ... navigate the impacts of the ACA. , The ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Lynn Lester, Director of Clinical Operations/CEO, Recovery Treatment Center, Into its VIP Woman of the Year Circle 2Health News:The National Association of Professional Women Inducts Kathy Everette-Gaines, Community Relations Coordinator, Into its VIP Professional Woman of the Year Circle 2Health News:Warriors NBA Finals Tickets: 2015 NBA Finals Feature the Golden State Warriors vs. the Cleveland Cavaliers 2Health News:Warriors NBA Finals Tickets: 2015 NBA Finals Feature the Golden State Warriors vs. the Cleveland Cavaliers 3Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 2Health News:Cambia Partners with AHIP to Offer Expert Series ACA Training Course 3
... May 12 ULURU Inc. (Amex: ULU ),today ... 31,2008., For the quarter ended March 31, 2008, ... $0.03 per share, compared to a net,loss of $847,000, ... 2007.,The first quarter 2008 net loss was impacted by ...
... Fish diet to avoid being beaten up, thrown out ... result. , That is the fascinating conclusion of the latest ... of Excellence for Coral Reef Studies and James Cook University, ... team who recently revealed fish use the threat of punishment ...
... FRANKLIN, Mass., May 12 PLC Systems Inc.,(AMEX: ... cardiac and vascular medical,device-based technologies, announced today that ... annual meeting of the European,Association of Percutaneous Cardiovascular ... than 11,000 clinicians and,professionals are expected to attend ...
... Study finds little more than half of patients were checked, ... News) -- The dangers of high blood pressure are well-known, ... pressure screening in doctor,s offices and a low percentage of ... , The Stanford University School of Medicine study, published in ...
... 08:30 a.m. EDT at ... http://www.isispharm.com , CARLSBAD, Calif., ... financial results,for the quarter ended March 31, 2008. The Company finished the ... expense related to stock options, compared to a pro forma NOL,of $18.5 ...
... MARKHAM, ON, May 12 /PRNewswire-FirstCall/ - Innolife Pharma, ... over the previous eight,months regarding the formation of ... in these negotiations where final written terms have ... to the Company,s very first,product acquisition. It should ...
Cached Medicine News:Health News:ULURU Inc. Reports First Quarter 2008 Financial Results 2Health News:ULURU Inc. Reports First Quarter 2008 Financial Results 3Health News:ULURU Inc. Reports First Quarter 2008 Financial Results 4Health News:ULURU Inc. Reports First Quarter 2008 Financial Results 5Health News:ULURU Inc. Reports First Quarter 2008 Financial Results 6Health News:Fish diet to avoid fights 2Health News:PLC Medical Systems to Demonstrate RenalGuard(TM) at EuroPCR 2008 2Health News:PLC Medical Systems to Demonstrate RenalGuard(TM) at EuroPCR 2008 3Health News:PLC Medical Systems to Demonstrate RenalGuard(TM) at EuroPCR 2008 4Health News:High Blood Pressure Still Slipping Past Doctors 2Health News:High Blood Pressure Still Slipping Past Doctors 3Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 2Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 3Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 4Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 5Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 6Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 7Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 8Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 9Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 10Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 11Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 12Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 13Health News:Isis Reports Financial Results and Highlights for First Quarter of 2008 14Health News:Innolife Pharma Provides Initial Update on Negotiations for Significant Product Joint Venture 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: